Baker Brothers Advisors - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$969,000
-54.1%
613,1440.0%0.01%
-64.3%
Q3 2019$2,109,000
-6.8%
613,1440.0%0.01%
-6.7%
Q2 2019$2,263,000
-64.8%
613,1440.0%0.02%
-63.4%
Q1 2019$6,432,000
+1.0%
613,1440.0%0.04%
-21.2%
Q4 2018$6,371,000
-13.8%
613,1440.0%0.05%
+6.1%
Q3 2018$7,388,000
+67.1%
613,144
+64.3%
0.05%
+48.5%
Q2 2018$4,422,000
-22.9%
373,1440.0%0.03%
-32.7%
Q1 2018$5,739,000
+14.4%
373,1440.0%0.05%
+14.0%
Q4 2017$5,015,000
-20.2%
373,1440.0%0.04%
-15.7%
Q3 2017$6,284,000
+24.4%
373,1440.0%0.05%
+15.9%
Q2 2017$5,052,000
+158.8%
373,144
+70.2%
0.04%
+175.0%
Q1 2017$1,952,000
+11.4%
219,2980.0%0.02%
-5.9%
Q4 2016$1,752,000219,2980.02%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders